News from Globe Newswire

Follow

Globe Newswire

See all of Globe Newswire news coverage in one place. Discover how Globe Newswire’s media bias informs their coverage and compare with thousands of other news outlets.

We’ve discovered 24,479 headlines written by Globe Newswire during the past 3 months.

The Ground News media bias check for Globe Newswire is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

If you want to know if Globe Newswire is credible or reliable, look no further. We rank Globe Newswire as unknown factuality. Find out more about our methodology here.

Follow

See all of Globe Newswire news coverage in one place. Discover how Globe Newswire’s media bias informs their coverage and compare with thousands of other news outlets. We’ve discovered 24,479 headlines written by Globe Newswire during the past 3 months.

The Ground News media bias check for Globe Newswire is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides. If you want to know if Globe Newswire is credible or reliable, look no further. We rank Globe Newswire as unknown factuality. Find out more about our methodology here.

Information about Globe NewswireWhere is Globe Newswire located?Globe Newswire's WebsiteGlobe Newswire's Twitter

Ownership

Who owns Globe Newswire?

Other: Intrado

Private Equity: Apollo Global Management

Factuality

How credible is the news from Globe Newswire?

Unknown by Ad Fontes Media and Media Bias/Fact Check

Media Bias Ratings

Does Globe Newswire lean left or right?

See how media bias works at Ground News

Top Globe Newswire News

Business · New York

Pfizer agrees to buy Global Blood Therapeutics in deal valued at $5.4 billion: WSJ

51% Center coverage: 37 sources

Pfizer will pay $68.50-a-share in cash for Global Blood Therapeutics. The companies are expected to announce the deal later Monday. The news comes after the Wall Street Journal reported Friday that the two were in advanced talks. Global Blood Therapeutics has one of few approved treatments for sickle-cell disease.See the Story

Business

UPS nears deal to buy Italian healthcare-logistics provider Bomi Group

50% Center coverage: 6 sources

UPS is nearing a deal to acquire Italian healthcare-logistics company Bomi Group, the Wall Street Journal reported. The deal, worth several hundred million dollars, could be finalized as soon as Monday, the report said. UPS did not immediately respond to a Reuters request for comment.See the Story

CANOO INC. ANNOUNCES SECOND QUARTER 2022 RESULTS

100% Center coverage: 2 sources

Canoo Inc. announced its financial results for the second quarter of 2022. Walmart signed definitive agreement to purchase 4,500 units, beginning with the Lifestyle Delivery Vehicle (LDV), with an option to purchase up to 10,000 units. Canoo has more than $1 billion in its sales pipeline.See the Story

Latest News Stories

Syndax Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update

100% Center coverage: 2 sources

Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX) today reported its financial results and provided a business update for the second quarter ended June 30, 2022. On track to report topline data from revumenib and axatilimab pivotal programs starting in 1H23. Updated data from Phase 1 portion of AUGMENT-101 trial expected in 4Q22. Company to host conference call today at 4:30 p.m. ET.See the Story

Blockchain in FinTech Market Size To Reach USD 31.4 Billion By 2030 With 47.9% CAGR - Report by Market Research Future (MRFR)

100% Center coverage: 3 sources

Blockchain in FinTech Market is poised to reachUSD 31.4 billion by 2030, registering an 47.9% CAGR throughout the forecast period (2021 to 2030) The report segments the market dynamics into service providers, interaction channels, organization size, applications, and regions. North America heads the global blockchain in fintech market, witnessing the growing adoption of advanced technologies.See the Story

Business

Orbital Infrastructure Group Schedules Second Quarter 2022 Financial Results Conference Call for Thursday, August 11, 2022

67% Center coverage: 3 sources

Orbital Infrastructure Group, Inc. (Nasdaq: OIG) will issue its financial results for the second quarter ended June 30, 2022 before the market opens on Thursday, August 11, 2022. Vice Chairman and CEO Jim O'Neil and CFO Nick Grindstaff will host a conference call to discuss the results. To access the call, please dial (412) 317-1826.See the Story

Verona Pharma to Announce Top-line Data from Phase 3 ENHANCE-2 Trial of Nebulized Ensifentrine for COPD

100% Center coverage: 1 sources

Verona Pharma plc will report top-line Phase 3 data from its ENHANCE-2 trial of nebulized ensifentrine and its financial results for the second quarter ended June 30, 2022 on August 9, 2022. The Company will host an investment community webcast and conference call at 8:30 a.m. EDT. Antonio Anzueto, MD, Professor of Medicine and Section Chief of Pulmonary at South Texas Veterans Healthcare System, will join Verona Pharma's management team on the call.See the Story

Medexus Announces Record Fiscal Q1 2023 Revenue of US$23.0 Million, a 33% Increase versus Fiscal Q1 2022

100% Center coverage: 1 sources

Results include first U.S. revenue from Gleolan, full commercial launch expected in fiscal Q2 Treosulfan NDA resubmitted to the FDA, regulatory...See the Story

BikeN, A Bike-To-Earn crypto project is starting its presale in a week

100% Center coverage: 1 sources

BikeN is a Web3 bike-to-earn lifestyle app with metaverse integration focused on biking and fitness. People can exercise, earn, compete, and interact while they bike using the apps indoor and outdoor modes. The project plans to host future competitions and Cycling Marathons where players can compete online.See the Story

Clearside Biomedical Enters into Non-Dilutive Financing Agreement with HealthCare Royalty Partners for up to $65 Million

100% Center coverage: 1 sources

Clearside Biomedical, Inc. has entered into a Royalty Interest Purchase and Sale Agreement (the agreement) with HealthCare Royalty Partners. Clearside intends to use the proceeds from the agreement to support ongoing clinical development of its pipeline. The agreement includes customary provisions for a transaction of this nature. Bausch + Lomb, a leading global eye health company, has the exclusive license for the commercialization and development of XIPERE in the United States and Canada.See the Story

Root, Inc. Announces 2022 Second Quarter Results; Moving Forward with Reverse Stock Split at 1-for-18 Ratio

100% Center coverage: 1 sources

Root announced today that it will proceed with a 1-for-18 reverse stock split previously approved by Root stockholders at the annual meeting of shareholders on June 7, 2022. Root will host a conference call and earnings webcast to discuss the results tomorrow, August 9, at 9:00 a.m. Eastern Time. To listen to the live audio webcast, please visit the News & Events section of Root's Investor Relations website at ir.joinroot.com.See the Story

Latest Tweet
from Globe Newswire

Topics Most Covered by Globe Newswire

Business

Blockchain

FDA

Oil and Gas Sector

NFT

Business

Blockchain

FDA

Sources Covering Similar sources

quotemedia.com

Green Stock News

Business Wire

Financial Post

prnewswire.com

quotemedia.com

Green Stock News

Business Wire

Suggest a source

Looking for a source we don't already have? Suggest one here.

Breaking News Topics Related to Globe Newswire

United States

British Columbia

Canada

Florida, United States

Business